ReviewMedical sciences (Basel, Switzerland)2026
From Automated ECG Interpretation to Multimodal Cardiovascular Intelligence: The Evolution of Artificial Intelligence in Cardiovascular Medicine.
Review in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) is rapidly transforming cardiovascular medicine, driven by the increasing availability of large-scale clinical data and advances in machine learning. Early computational applications in cardiology were primarily limited to rule-based electrocardiogram interpretation systems. Over time, these approaches have evolved into sophisticated deep learning models capable of analysing complex cardiovascular signals and imaging data. In parallel with the broader development of digital health technologies, including wearable devices, electronic health records, and remote monitoring systems, AI applications have expanded across multiple domains of cardiovascular care. These now include electrocardiographic (ECG) and electrophysiological analysis, cardiovascular imaging, surgical planning, and multimodal risk prediction. More recently, multimodal AI models have emerged that integrate heterogeneous data sources such as imaging, physiological signals, clinical records, and genomic information, enabling more comprehensive characterisation of cardiovascular disease. Beyond diagnostic applications, AI is increasingly influencing system-level aspects of cardiovascular medicine, including clinical decision support, workflow optimisation, medical education, and clinical trial design. This narrative review traces the historical and clinical evolution of artificial intelligence in cardiovascular medicine from early automated ECG interpretation systems to contemporary multimodal and system-level applications. It highlights key technological developments, current clinical applications, translational challenges, and the emerging role of AI within digital cardiovascular health ecosystems, with particular emphasis on early disease detection, risk stratification, prognostic modelling, and personalised cardiovascular care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.